Target Name: PRADC1
NCBI ID: G84279
Other Name(s): protease-associated domain-containing protein of 21 kDa | Protease-associated domain-containing protein of 21 kDa | protease-associated domain-containing glycoprotein 21 kDa | Protease-associated domain-containing protein 1 | PAP21 | Protease-associated domain-containing glycoprotein 21 kDa | C2orf7 | protease associated domain containing 1 | Protease associated domain containing 1, transcript variant 1 | hPAP21 | PADC1_HUMAN | PRADC1 variant 1

PRADC1: A Potential Drug Target and Biomarker

Protease-associated domain-containing protein of 21 kDa (PRADC1) is a protein that is expressed in various tissues and cell types in the human body. It is characterized by the presence of a unique domain that is involved in the regulation of proteases, which are enzymes that break down other proteins. PRADC1 has also been shown to play a role in cell signaling and inflammation.

The discovery and characterization of PRADC1 came about through a combination of biochemical, cellular, and structural studies. Researchers found that PRADC1 was a component of the endoplasmic reticulum (ER), which is the system for transporting and processing proteins in the cell. Additionally, they found that PRADC1 was involved in the regulation of proteolytic enzymes, which are enzymes that break down other proteins.

These findings suggested that PRADC1 may be a drug target or biomarker for various diseases. For example, PRADC1 has been shown to be involved in the regulation of proteolytic enzymes that can contribute to the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Additionally, PRADC1 has also been shown to be involved in the regulation of cancer cell growth and metastasis.

In addition to its potential role in disease, PRADC1 also has potential as a drug target. The unique domain of PRADC1 has been shown to be involved in the regulation of proteolytic enzymes, which makes it a potential target for small molecules that can inhibit the activity of these enzymes. Additionally, the regulation of proteolytic enzymes is also a potential target for anti-inflammatory drugs, as many of these drugs work by inhibiting the activity of proteolytic enzymes.

In conclusion, PRADC1 is a protein that has the potential to be a drug target or biomarker for various diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Protease Associated Domain Containing 1

Functions: Plays a role in the modulation of physical activity and adiposity

More Common Targets

PRAF2 | PRAG1 | PRAM1 | PRAME | PRAMEF1 | PRAMEF10 | PRAMEF11 | PRAMEF12 | PRAMEF14 | PRAMEF15 | PRAMEF16 | PRAMEF17 | PRAMEF18 | PRAMEF19 | PRAMEF2 | PRAMEF20 | PRAMEF22 | PRAMEF27 | PRAMEF29P | PRAMEF3 | PRAMEF36P | PRAMEF4 | PRAMEF5 | PRAMEF6 | PRAMEF7 | PRAMEF8 | PRAMEF9 | PRANCR | PRAP1 | PRB1 | PRB2 | PRB3 | PRB4 | PRC1 | PRC1-AS1 | PRCC | PRCD | PRCP | PRDM1 | PRDM10 | PRDM10-DT | PRDM11 | PRDM12 | PRDM13 | PRDM14 | PRDM15 | PRDM16 | PRDM16-DT | PRDM2 | PRDM4 | PRDM5 | PRDM6 | PRDM7 | PRDM8 | PRDM9 | PRDX1 | PRDX2 | PRDX2P4 | PRDX3 | PRDX4 | PRDX5 | PRDX6 | Pre-mRNA cleavage complex II | PREB | PRECSIT | Prefoldin complex | PRELID1 | PRELID1P6 | PRELID2 | PRELID3A | PRELID3B | PRELP | Prenyl diphosphate synthase | Prenyltransferase | PREP | PREPL | Presenilin | PREX1 | PREX2 | PRF1 | PRG1 | PRG2 | PRG3 | PRG4 | PRH1 | PRH1-PRR4 | PRH1-TAS2R14 | PRH2 | PRICKLE1 | PRICKLE2 | PRICKLE2-AS1 | PRICKLE2-AS2 | PRICKLE3 | PRICKLE4 | PRIM1 | PRIM2 | PRIM2BP | PRIMA1 | PRIMPOL | PRINS